Display Settings:

Format

Send to:

Choose Destination
    Ir J Med Sci. 2010 Sep;179(3):431-3. Epub 2009 Apr 8.

    Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis.

    Source

    Department of Urology, University College Hospital Galway, Galway, Ireland. steconnolly@rcsi.ie

    Abstract

    INTRODUCTION:

    The use of recombinant activated factor VII has been described for many clinical scenarios, but the value of this therapeutic agent for life-threatening haemorrhagic cystitis remains novel.

    METHOD:

    We describe a case of persistent life-threatening haemorrhagic radiation cystitis, and discuss current knowledge of this therapy including potential complications.

    RESULT:

    Control of haemorrhage was successfully achieved only after use of this agent.

    CONCLUSION:

    This therapy deserves mention in any future management algorithm devised for this condition.

    PMID:
    19352582
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk